Gemini Law LLP
Kyle Musgrove is a seasoned IP trial lawyer and counselor with a focus on the life sciences industry, currently serving as a Partner at Gemini Law LLP since February 2024. Musgrove has previously held partner positions at Parker Poe Adams & Bernstein LLP and Haynes and Boone, LLP, contributing extensive legal expertise in intellectual property. In addition to legal practice, Musgrove is a Board Member of The Arts Empowerment Project, a nonprofit dedicated to providing arts experiences for children to enhance their resilience and life skills. Musgrove holds a J.D. from the University of North Carolina School of Law and a B.S. in Chemical Engineering from Tulane University.
This person is not in any teams
Gemini Law LLP
Gemini’s life sciences lawyers are among the most experienced and successful at helping manufacturers of biopharma products navigate IP barriers to access the U.S. market. Gemini has an innovative and cost-effective structure among top-tier life-sciences firms: our attorneys work remotely with very little overhead, allowing us to pass substantial savings onto our clients. Gemini has particular expertise in patent strategy and litigation relating to biosimilar, biobetter, generic and 505(b)(2) products, as well as collateral issues concerning the Hatch-Waxman and BPCIA regulatory schemes. Gemini is also very experienced in counseling early-stage biotech companies to optimize patent portfolios and mitigate the risk posed by competitors’ IP, as well as IP issues related to licensing and development transactions. Gemini offers “end to end” counseling on IP issues in support of biopharma product development and launch in the U.S. To learn more, visit us at www.geminilaw.com